Biogen Idec Chief Counsel Resigns Amid Tysabri Withdrawal, Wrongful Discharge Suit
This article was originally published in The Pink Sheet Daily
Executive Summary
Thomas Bucknam’s resignation as chief counsel of Biogen Idec comes less than two weeks after the marketing suspension of Tysabri, and three weeks after a wrongful discharge suit is brought against the company. VP and Chief Corporate Counsel Anne Marie Cook will serve as acting general counsel.